Total raised
$2.0M
Last: Convertible Debt 2018-11
Stage
Series A
Founded
2015
Headcount
2
HQ
Kefar Sava
Sector
Health Tech & Life Sciences
About
Epitech MAG develops a noninvasive medical device and method for the treatment of dry eye syndrome. The company's noninvasive ocular neurostimulation therapy is designed to treat the entire ocular surface and tear film by enabling zero-contact, affordable, easily adopted procedures for long-lasting relief from dry eye symptoms. Epitech's proprietary technology is based on repetitive magnetic stimulation, which uses targeted magnetic fields to stimulate the peripheral branches of the trigeminal nerve, resulting in the reinforcement of the ocular surface's structural integrity.
Funding history · 2 rounds · $2.0M total
2018-11
Convertible Debt
$650K
Date unknown
Series A
$1.4M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-deviceshealthcare-providersnon-invasiveophthalmologyeye-diseasesbioconvergence